You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Ustekinumab

Showing 26 - 50 of 226
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Healthy Trial in Tempe, Lincoln, Salt Lake City (Ustekinumab)

Completed
  • Healthy
  • Ustekinumab
  • Tempe, Arizona
  • +2 more
Feb 22, 2022

Psoriatic Arthritis Trial in Frankfurt am Main (Methotrexate, Ustekinumab, Placebo)

Completed
  • Psoriatic Arthritis
  • Frankfurt am Main, Hessia, Germany
    CIRI
Mar 1, 2022

Healthy Trial in Rennes (Ustekinumab)

Completed
  • Healthy
  • Ustekinumab
  • Rennes, France
    Biotrial Rennes
Apr 3, 2022

Psoriasis Trial in Brisbane, Adelaide, Grafton (BFI-751, EU-STELARA®, US-STELARA®)

Completed
  • Psoriasis
  • Brisbane, Queensland, Australia
  • +2 more
Mar 23, 2022

Inflammatory Bowel Disease in Egyptian Patients

Completed
  • IBD
    • Cairo, Egypt
      Faculty of pharmacy-Helwan University
    Feb 7, 2023

    Psoriasis Trial in Cleveland (Ustekinumab)

    Not yet recruiting
    • Psoriasis
    • Ustekinumab
    • Cleveland, Ohio
      University Hospitals Cleveland Medical Center
    Jul 6, 2022

    Ulcerative Colitis Trial in Miami (Tofacitinib, Fast Mimicking Diet, Ustekinumab induction)

    Recruiting
    • Ulcerative Colitis
    • Miami, Florida
    • +1 more
    Apr 22, 2022

    Fate in Fistulizing Crohn's Disease in a Pediatric Population

    Active, not recruiting
    • Crohn Disease
    • (no location specified)
    Feb 25, 2023

    Ustekinumab Assessing Efficacy and Healthcare Resource

    Completed
    • Crohn Disease
    • Ustekinumab
    • Örebro, Sweden
      Universitetssjukhuset Örebro
    Feb 11, 2022

    Crohn Disease, Ulcerative Colitis Trial in Worldwide (Ustekinumab IV Infusion, Ustekinumab SC Injection, Midazolam 2 mg)

    Suspended
    • Crohn Disease
    • Ulcerative Colitis
    • Ustekinumab IV Infusion
    • +7 more
    • Cypress, California
    • +15 more
    Jul 21, 2022

    Behçet Disease Trial in Paris (Subcutaneous Ustekinumab)

    Completed
    • Behçet Disease
    • Subcutaneous Ustekinumab
    • Paris, France
      Hôpital Cochin, Department of Internal Medicine, National Refere
    Nov 19, 2021

    Psoriasis Trial in Australia, New Zealand (Stelara PFS)

    Completed
    • Psoriasis
    • Stelara PFS
    • Brisbane, Australia
    • +3 more
    May 20, 2022

    Patients With Crohn's Disease

    Recruiting
    • Crohn Disease
      • Sevilla, Spain
        Hospital Universitario Virgen de Macarena
      Nov 15, 2021

      Crohn Disease, Colitis, Ulcerative, Arthritis, Psoriatic Trial in Worldwide (Ustekinumab)

      Recruiting
      • Crohn Disease
      • +2 more
      • Ustekinumab
      • Atlanta, Georgia
      • +24 more
      Aug 17, 2022

      Symptom Improvement of Ulcerative Colitis AfterInduction Dose of

      Active, not recruiting
      • Ulcerative Colitis
      • Ustekinumab
      • Bunkyo-ku, Japan
      • +23 more
      Aug 17, 2022

      Psoriasis Trial (risankizumab, ustekinumab, for risankizumab)

      Completed
      Has Results
      • Psoriasis
      • (no location specified)
      Jul 28, 2021

      Psoriasis Trial in Worldwide (Ustekinumab 0.75 mg/kg, Ustekinumab 45 mg, Ustekinumab 90 mg)

      Completed
      Has Results
      • Psoriasis
      • Ustekinumab 0.75 mg/kg
      • +2 more
      • San Diego, California
      • +30 more
      Sep 30, 2021

      Combined Microbiota and Metabolic Signature in Ulcerative

      Not yet recruiting
      • Ulcerative Colitis
      • (no location specified)
      Jan 26, 2023

      Psoriasis Trial (risankizumab, for risankizumab, ustekinumab)

      Completed
      Has Results
      • Psoriasis
      • (no location specified)
      Jul 28, 2021

      Ulcerative Colitis Trial in Edmonton (Lyophilized fecal microbiota (LFMT), Placebo)

      Recruiting
      • Ulcerative Colitis
      • Lyophilized fecal microbiota (LFMT)
      • Placebo
      • Edmonton, Alberta, Canada
        University of Alberta Hospital
      Jul 6, 2022

      Crohn Disease Trial in China (Ustekinumab)

      Recruiting
      • Crohn Disease
      • Ustekinumab
      • Beijing, China
      • +28 more
      Aug 17, 2022

      Psoriasis, Moderate to Severe Plaque Psoriasis Trial in Worldwide (Stelara® (Ustekinumab), SB17 (Proposed Ustekinumab

      Active, not recruiting
      • Psoriasis
      • Moderate to Severe Plaque Psoriasis
      • Stelara® (Ustekinumab)
      • SB17 (Proposed Ustekinumab Biosimilar)
      • Brno, Czechia
      • +32 more
      Apr 13, 2022

      Takayasu Arteritis Trial in Japan (Ustekinumab, Placebo, Glucorticoid Taper Regimen)

      Recruiting
      • Takayasu Arteritis
      • Ustekinumab
      • +2 more
      • Bunkyo-Ku, Japan
      • +28 more
      Aug 16, 2022

      Psoriatic Arthritis Trial in Germany (Secukinumab, Ustekinumab)

      Recruiting
      • Psoriatic Arthritis
      • Secukinumab
      • Ustekinumab
      • Frankfurt, Hesse, Germany
      • +36 more
      Jul 20, 2022

      Psoriasis Trial in Barcelona, Granada, Pontevedra (Brodalumab, Ustekinumab, Placebo)

      Recruiting
      • Psoriasis
      • Brussels, Bruxelles-Capitale, Belgium
      • +21 more
      Jan 27, 2023